VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: EyeDrMike who wrote (6115)	3/24/1998 5:51:00 PM
From: RT	Read Replies (1) of 23519

<<TALKING POINT/Viagra is Pfizer's double-edge sword By Ransdell Pierson "I'd say most people would prefer an oral pill over an injection," Ryan said. Caverject had worldwide sales of $88 million in 1997, somewhat higher than MUSE revenues.>> Eye Dr Mike, This chick Barbara Ryan is really on the ball. Barbara Ryan says, Caverject had worldwide sales of 88 million in 1997, somewhat higher than Vivus. I thought Vivus had 138 million in revenues. Then again, I'm not a science fiction writer, so what do I know? RT

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next